DrugDev.org Insiders' Site ID and Study Start-Up Report: 50% of Sites Miss Recruitment Target

June 25, 2012

Company News Release

DrugDev.org, a global interactive network of clinical trial doctors –presented its Insiders’ Site ID and Study StartUp Report at DIA 2012. Key results from the survey of over 220 project managers from large pharma, small pharma/biotech and CROs were:

56% of clinical trial sites do NOT deliver the expected number of patients
It takes Pharma an average of 6.46 weeks to identify sites, compared to 2 days with best in class offerings,
despite this only 32% are unsatisfied with waiting this long
61% of respondents agreed that there were major challenges with finding good investigators in particular
regions however there was no consensus on where those regions were 84% of respondents from Pharma felt that early engagement with potential investigators would increase recruitment
rates and yet none were looking into early engagement

Candice Yarde, VP of Business Development, DrugDev.org said,“The results of the survey ran the full gamut
from mundane and predictable through to surprising and even shocking. The
relatively high level of satisfaction with existing processes, despite lagging timelines and high rates of site underperformance, highlights a worrying disconnect between senior R&D
leadership,which is demanding transformational improvement and project teams that
have come to accept historical performance as standard.”

Earlier this year, DIA provided companies the opportunity to submit an application detailing how they
embodied the characteristics of “collaboration” and “innovation” and how they fostered th
ose characteristics in their offerings. A DIA panel reviewed the applications and selected five winning entrepreneurs,
including DrugDev.org to showcase their work in the Entrepreneur Pavilion in Booth 1709.